ZLMCON Regenerative Medicine Technology (Guangzhou) Co., Ltd
ABOUT US

Located in the Guangzhou Innovation Base of Tsinghua Science and Technology Park, Panyu District, Guangzhou, ZLMCON Regenerative Medicine Technology (Guangzhou) Co., Ltd. is a bio-high-tech enterprise in the field of cell and gene therapy, mainly engaged in the research and development, production, application, promotion and cell storage of stem cell and immune cell technology.


The company's main technical personnel have more than 20 years of practical experience, accumulated rich practical experience in cell culture process and quality control system, and have a number of original technologies, and the stem cells and immune cells produced are in the leading position in the industry in terms of safety, efficacy and flow cytometry purity.

Popular Services Display

Human mesenchymal stem

cells


Adipose stem cells


NK cells


CIK cells

Umbilical cord mesenchymal stem cells


Umbilical cord mesenchymal stem cells (UC-MSCs) are a type of pluripotent stem cells derived from human umbilical cord tissue, possessing self-renewal and multi-directional differentiation potential. Not only can UC-MSCs differentiate into various cell types (such as osteocytes, chondrocytes, adipocytes, etc.), but they also exhibit potent immunomodulatory functions and tissue repair capabilities. UC-MSCs focus on directions such as nerve repair, anti-inflammation, and anti-allergy. Due to their non-invasive collection process, high safety, and abundant source, they have broad application prospects in the fields of regenerative medicine and cell therapy.

Natural killer cells


Natural killer cells are a group of lymphocytes that kill target cells (mutant cells) without relying on antibodies or antigen stimulation, so they are called natural killer cells. It is an immune cell that is the first to respond to protect the body. It is a major member of the body's innate immune system, has the ability to recognize, and plays an important role in killing virus-infected cells and tumor cells

γδ T cell cells


γδ T cells γδ T cells are a class of T lymphocytes with unique T cell receptors (TCRs), which are different from traditional αβ T cells. γδ T cells play an important role in both innate and adaptive immunity, and can respond quickly to pathogen and tumor cell invasion. They do not rely on antigen presentation from major histocompatibility complex (MHC) molecules and are characterized by a rapid and broad-spectrum immune response

Company advantages
High-specification laboratory
GMP compliant, B+A clean grade
Full life cycle management system
Full traceability, automatic monitoring, quality and quantity
5S on-site management
Establish a standardized, efficient and clean working environment to promote the sustainable development of the enterprise.
Patented technology leading
Obtained more than 50 national patents
Advanced analytical equipment
The main instruments and equipment of the experimental center include 1llumina series DNA sequencer and Leica series microscope to meet the research and development needs of different projects.
Experienced team of experts
They lead the industry with excellent professionalism, rich experience and high innovation ability.
HIGH QUALITY SUPPLIER OF SCIENTIFIC RESEARCH SERVICE
Our competitive advantage
  • Perfect research platform
  • Cooperation platform
  • Experimental equipment
  • Standardize the experimental site
  • Professional technical team


Perfect research platform


Cell Biology Research Platform, Molecular Biology Research Platform, Pathology Research Platform, Immunology Research Platform, Transgenic and Model Animal Research Platform, Protein and Peptide Research Platform; CRISPR/Cas9 targeted gene modification drug development platform, nano-targeted drug delivery innovation platform, high-throughput/high-content screening platform, molecular epigenetic research platform.


High-quality cooperation platform


The company attaches great importance to industry-university-research cooperation, and jointly establishes a joint laboratory of biological cells with the Institute of Biological and Medical Engineering of the Guangdong Academy of Sciences and the Guangdong Institute of Military-Civil Integration Industry of Zhongke. The joint laboratory brings together a group of top experts in the field of biological cells, and has carried out applied research in the treatment and rehabilitation of anti-aging, chronic diseases (diabetes, stroke, premature ovarian failure, autoimmune diseases, etc.), tumors (lung cancer, liver cancer, stomach cancer, cervical cancer, breast cancer, etc.), and has accumulated rich clinical data. Strive to provide better solutions for Chinese people for chronic diseases, tumors and other intractable diseases, and escort human health.


Advanced experimental equipment


The main instruments and equipment of the joint central laboratory include ultra-high-speed centrifugation system, tangential flow filtration system, high-precision carbon dioxide incubator, SCIEX series mass spectrometer, Leica series microscope, BD flow cytometry analyzer, capillary electrophoresis, protein detection analyzer, high-efficiency gas phase instrument, etc., and more instruments and equipment will be added one after another to meet the research and development needs of different projects.


Standardize the experimental site


The laboratory focuses on the R&D and production of clinical-grade cell culture products, and is a domestic cell culture solution provider, covering the fields of expansion, cryopreservation and isolation in stem cell and immune cell therapy. The company's technical team can also provide production technology development services (CRO) and pilot and commercial-scale contract manufacturing services (CMO) for cell medicine companies, and finally rely on technical and technological advantages to provide customers with standardized products, but also provide customers with one-stop personalized customization services from R&D, production and after-sales.


Professional technical team


In order to adapt to the high-quality development of national health, promote the technical research of stem cells, and better serve people's health, the Guangdong Academy of Sciences Military-Civilian Integration Life and Health Innovation Center (jointly established by the Institute of Biology and Medical Engineering of the Guangdong Academy of Sciences and the Guangdong Institute of Military-Civilian Integration of Chinese Science and Technology) and Zhonglai Meikang Regenerative Medicine Technology (Guangzhou) Co., Ltd. jointly established the Biological Cell Joint Laboratory, which is an important R&D platform of the Military-Civilian Integration Innovation Center. The laboratory expert group is composed of experts from the Guangdong Academy of Sciences, military laboratories, Sun Yat-sen University Cancer Hospital, military hospitals, local hospitals, and enterprise technology. Carry out a series of research on biological cells.